s6y

Renalytix plc

Ticker
RNLXY, RENXF
CIK
1811115
Industry
Services-Medical Laboratories
Formerly
Renalytix AI plc

Financials 8

  1. 10-Q Quarterly Report for period ending Sep 30, 2024
  2. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2024
  3. 10-K Annual Report for period ending Jun 30, 2024
  4. 10-Q Quarterly Report for period ending Mar 31, 2024
  5. 10-Q Quarterly Report for period ending Dec 31, 2023
  6. 10-Q Quarterly Report for period ending Sep 30, 2023
  7. 10-K/A Annual Report for period ending Jun 30, 2023
  8. 10-K Annual Report for period ending Jun 30, 2023

News 45

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K/A Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K/A Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 45 news filings

Ownership 43

  1. SC 13G/A Major Shareholders
  2. SC 13D/A Major Shareholders
  3. SC 13D/A Major Shareholders
  4. 4 Statement of changes in beneficial ownership of securities
  5. SC 13D/A Major Shareholders
  6. 4 Statement of changes in beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. SC 13D/A Major Shareholders
  9. 4 Statement of changes in beneficial ownership of securities
  10. SC 13G Major Shareholders

All 43 ownership filings

Prospectus 22

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. S-3/A Registration statement for specified transactions by certain issuers
  6. S-3/A Registration statement for specified transactions by certain issuers
  7. S-3 Registration statement for specified transactions by certain issuers
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. S-3 Registration statement for specified transactions by certain issuers

All 22 prospectus filings

Proxies 10

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEF 14A Definitive proxy statements
  6. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  7. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  8. DEFR14A Definitive revised proxy soliciting materials
  9. DEF 14A Definitive proxy statements
  10. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition

Other 105

  1. SCHEDULE 13D/A
  2. F-6 POS Post-effective amendment to a F-6EF registration
  3. F-6 POS Post-effective amendment to a F-6EF registration
  4. EFFECT Notice of Effectiveness
  5. EFFECT Notice of Effectiveness
  6. EFFECT Notice of Effectiveness
  7. EFFECT Notice of Effectiveness
  8. EFFECT Notice of Effectiveness
  9. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  10. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing

All 105 other filings